Literature DB >> 22759902

External validity in randomised controlled trials of acupuncture for osteoarthritis knee pain.

Nithima Purepong1, Anusorn Jitvimonrat, Ekalak Sitthipornvorakul, Sukanya Eksakulkla, Prawit Janwantanakul.   

Abstract

OBJECTIVES: To assess two aspects of the external validity of acupuncture research for osteoarthritis knee pain and determine the common acupoints and treatment parameters used.
METHODS: The external validity of 16 randomised controlled trials (RCTs) was investigated using a scale consisting of two aspects: reporting and performance. The reporting aspect included acupuncturist's background, study location, treatment detailed, patient characteristics, positive trial results, adverse effects and between-group statistical differences, whereas treatment appropriateness, appropriate controls and outcomes were classified as the performance aspect. Acupuncture treatment in RCTs was compared with common practice according to the literature sources and survey of acupuncturists working in different parts of Thailand.
RESULTS: The levels of external validity for the reporting and performance aspects were in the range of 31.3% to 100%. Statistic values such as mean difference and confidence interval were reported by the minority of trials (43.8%). Patient satisfaction and quality of life were seldom used (31.3%). There were minor differences between research and practice in terms of the points used (25.0%), number of treatment sessions (6.3%) and frequency (12.5%). The most frequently used points were ST34, ST35, ST36, SP6, SP9, SP10, GB34, Xiyan and ah shi points, and the commonly used treatment parameters were 20 minutes, 10-15 sessions and two treatments weekly.
CONCLUSIONS: Reporting of the external validity of acupuncture RCTs for knee pain was notably inadequate in terms of trial setting, treatment provider and statistical reporting. The majority of studies involved appropriate controls and outcomes and applied acupuncture treatments in line with practice.

Entities:  

Mesh:

Year:  2012        PMID: 22759902     DOI: 10.1136/acupmed-2012-010140

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  7 in total

1.  Assessment of the quality of reporting for treatment components in Cochrane reviews of acupuncture.

Authors:  Kun Hyung Kim; Jung Won Kang; Myeong Soo Lee; Jae-Dong Lee
Journal:  BMJ Open       Date:  2014-01-17       Impact factor: 2.692

2.  Risk of bias and methodological issues in randomised controlled trials of acupuncture for knee osteoarthritis: a cross-sectional study.

Authors:  Pengli Jia; Li Tang; Jiajie Yu; Andy H Lee; Xu Zhou; Deying Kang; Yanan Luo; Jiali Liu; Xin Sun
Journal:  BMJ Open       Date:  2018-03-06       Impact factor: 2.692

3.  Mast cells are important regulator of acupoint sensitization via the secretion of tryptase, 5-hydroxytryptamine, and histamine.

Authors:  Ning Ding; Jing Jiang; Pingping Qin; Qiaoxia Wang; Jiatong Hu; Zhigang Li
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

4.  Effect of Moxibustion on the Intestinal Flora of Rats with Knee Osteoarthritis Induced by Monosodium Iodoacetate.

Authors:  Yu Chen; Jiuheng Lv; Yejuan Jia; Ruiqing Wang; Zidi Zhang; Jingxuan Liu; Chunsheng Jia
Journal:  Evid Based Complement Alternat Med       Date:  2020-07-04       Impact factor: 2.629

5.  Lack of association between acupoint sensitization and microcirculatory structural changes in a mouse model of knee osteoarthritis: A pilot study.

Authors:  Ning Ding; Xiaoxiao Liu; Ningbo Chen; Jing Jiang; Huangxuan Zhao; Zhigang Li; Jianhui Zhang; Chengbo Liu
Journal:  J Biophotonics       Date:  2019-03-06       Impact factor: 3.207

6.  The quality of reporting in randomized controlled trials of acupuncture for knee osteoarthritis: A cross-sectional survey.

Authors:  Pengli Jia; Li Tang; Jiajie Yu; Jiali Liu; Deying Kang; Xin Sun
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

7.  Laser Speckle Imaging of Sensitized Acupoints.

Authors:  Ning Ding; Jing Jiang; Xiaoxiao Liu; Yiyuan Xu; Jiatong Hu; Zhigang Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-17       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.